PETALING JAYA: Malaysia acquired the primary cargo of Covid-19 antiviral drug Paxlovid on April 9 and it’s enough to treat 48,000 patients, says the Health Ministry.
Minister Khairy Jamaluddin mentioned the medication are at present being distributed to authorities well being services nationwide which incorporates 481 Covid-19 Assessment Centre (CAC) well being clinics and 15 public hospitals.
“The antiviral drug will be used for Covid-19 patients aged 18 and above, with infection in Category 2 and 3 who do not need oxygen therapy, and those who are at higher risk of developing severe infection.
“Covid-19 patients who visit CACs and government hospitals will be assessed by medical officers before being treated with Paxlovid,” he mentioned on Thursday (April 14).
The ministry has acquired a complete of 104,700 Paxlovid programs, which can be distributed to Covid-19 patients at no cost.
Khairy mentioned that regardless of the drug having the ability to cut back worsening signs due to Covid-19 infections, it isn’t supposed to substitute vaccination and compliance to normal working procedures.
He added that on March 3, the Drug Control Authority conditionally accredited Paxlovid, which reduces the coronavirus’ capacity to replicate itself whereas bettering the physique’s immune system to battle the an infection.